Product Images Losartan Potassium
View Photos of Packaging, Labels & Appearance
- Figure 1 - 92296151 e507 41b4 a040 c01b87ecb982 01
- figure 2 - 92296151 e507 41b4 a040 c01b87ecb982 02
- figure 3 - 92296151 e507 41b4 a040 c01b87ecb982 03
- figure 4 - 92296151 e507 41b4 a040 c01b87ecb982 04
- figure 5 - 92296151 e507 41b4 a040 c01b87ecb982 05
- figure 6 - 92296151 e507 41b4 a040 c01b87ecb982 06
- figure 6 - 92296151 e507 41b4 a040 c01b87ecb982 07
- 71205-069-90 - 92296151 e507 41b4 a040 c01b87ecb982 08
Product Label Images
The following 8 images provide visual information about the product associated with Losartan Potassium NDC 71205-069 by Proficient Rx Lp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 - 92296151 e507 41b4 a040 c01b87ecb982 01
figure 2 - 92296151 e507 41b4 a040 c01b87ecb982 02
This appears to be a graph or a chart displaying the percentage of patients with a primary endpoint for two medications, Atenolol and Losartan Potassium Tablets, over a period of 65 months. It also shows an adjusted risk reduction percentage of 13% with a p-value of 0.021. It is unclear what the primary endpoint or the study is related to.*
figure 3 - 92296151 e507 41b4 a040 c01b87ecb982 03
The given information seems to be a graph or table showing the comparison between Atenolol and Losartan Potassium Tablets for patients with fatal or non-fatal stroke. It appears to display the percentages of patients in different time intervals, possibly months, on the x-axis and the percentage of patients with stroke on the y-axis. The graph also displays an 'adjusted risk reduction' of 25% with a significance level of p=0.001. However, without proper context, the interpretation of this graph is limited.*
figure 4 - 92296151 e507 41b4 a040 c01b87ecb982 04
figure 5 - 92296151 e507 41b4 a040 c01b87ecb982 05
The given text provides some data regarding the percentage of patients with an event. The text also includes the Risk Reduction percentage and a value of 0.022 for an unknown parameter. It seems to be related to the comparison of the efficacy of Losartan Potassium Tablets and Placebo but it lacks context and clarity to provide a useful description.*
figure 6 - 92296151 e507 41b4 a040 c01b87ecb982 06
figure 6 - 92296151 e507 41b4 a040 c01b87ecb982 07
71205-069-90 - 92296151 e507 41b4 a040 c01b87ecb982 08
Losartan Potassium 25mg tablets, each containing 25mg of losartan potassium, are oval shaped, white to off-white, biconvex, film-coated tablets with "25" and "113" debossed on one and the other side, respectively. These RX-only tablets are available in 30 packs, under NDC 71205-069-30, manufactured by Torrent Pharmaceuticals LTD, India, and distributed by Proficient Rx, Thousand Oaks, California. The tablets are to be stored at 20°-25°C (68°-77°F) and kept out of the reach of children, as per the package. Lot number, expiration date, and product-related identification numbers are also mentioned on the package.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
